We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.75B
AUM Growth
+$24.7M
Cap. Flow
-$74.5M
Cap. Flow %
-4.25%
Top 10 Hldgs %
27.66%
Holding
275
New
15
Increased
70
Reduced
162
Closed
18

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$10.8M
2
WNS
WNS Holdings
WNS
+$9.49M
3
FN icon
Fabrinet
FN
+$8.56M
4
ADMA icon
ADMA Biologics
ADMA
+$6.59M
5
YOU icon
Clear Secure
YOU
+$5.91M

Top Sells

Rank Stock Value
1
PGTI
PGT, Inc.
PGTI
+$25.4M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$15.9M
3
DOOR
MASONITE INTERNATIONAL CORP
DOOR
+$10.2M
4
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
+$6.67M
5
BBBY
Bed Bath & Beyond
BBBY
+$5.67M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 23.6%
3 Industrials 20.85%
4 Communication Services 5.79%
5 Consumer Staples 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRN icon
1
Stride
LRN
$3.48B
$58.4M 3.33%
925,780
-21,032
-2% -$1.27M
DFIN icon
2
Donnelley Financial Solutions
DFIN
$1.21B
$56.9M 3.25%
917,210
-31,256
-3% -$1.95M
DOOR
3
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$51.9M 2.96%
394,498
-90,248
-19% -$10.2M
ARLO icon
4
Arlo Technologies
ARLO
$1.59B
$51.4M 2.93%
4,061,255
+421,708
+12% +$4.21M
MEDP icon
5
Medpace
MEDP
$16B
$49.3M 2.81%
121,885
-5,755
-5% -$2.02M
ACIW icon
6
ACI Worldwide
ACIW
$5.81B
$46.7M 2.66%
1,405,389
-58,256
-4% -$1.8M
PBH icon
7
Prestige Consumer Healthcare
PBH
$2.35B
$45.7M 2.61%
630,079
-36,534
-5% -$2.44M
WNS
8
DELISTED
WNS Holdings
WNS
$44.8M 2.56%
885,809
+157,336
+22% +$9.49M
EEFT icon
9
Euronet Worldwide
EEFT
$2.77B
$41.8M 2.38%
379,826
-10,826
-3% -$1.14M
TKO icon
10
TKO Group
TKO
$13.5B
$37.9M 2.16%
438,687
-11,897
-3% -$990K
ESTA icon
11
Establishment Labs
ESTA
$2.72B
$37.6M 2.14%
738,020
-12,889
-2% -$517K
XPO icon
12
XPO
XPO
$23.6B
$35.4M 2.02%
290,409
-11,678
-4% -$1.25M
AGM icon
13
Federal Agricultural Mortgage
AGM
$2.38B
$31.5M 1.8%
159,866
-3,310
-2% -$616K
PCRX icon
14
Pacira BioSciences
PCRX
$1.04B
$30.5M 1.74%
1,043,540
+7,571
+0.7% +$233K
AWI icon
15
Armstrong World Industries
AWI
$7.31B
$28.5M 1.63%
229,697
-9,703
-4% -$1.07M
ZD icon
16
Ziff Davis
ZD
$1.92B
$26M 1.49%
413,050
-15,427
-4% -$1.02M
IOVA icon
17
Iovance Biotherapeutics
IOVA
$1.9B
$25.4M 1.45%
1,713,825
-37,082
-2% -$432K
ASND icon
18
Ascendis Pharma A/S
ASND
$16.1B
$24.6M 1.4%
162,412
-6,471
-4% -$924K
AX icon
19
Axos Financial
AX
$5.69B
$21M 1.2%
388,256
-69,436
-15% -$3.65M
DOCS icon
20
Doximity
DOCS
$3.75B
$20.8M 1.19%
774,444
+30,426
+4% +$867K
LGND icon
21
Ligand Pharmaceuticals
LGND
$5.84B
$20.5M 1.17%
279,784
+3,776
+1% +$278K
FC icon
22
Franklin Covey
FC
$236M
$20.2M 1.16%
515,446
-18,390
-3% -$733K
NGVT icon
23
Ingevity
NGVT
$2.48B
$18.6M 1.06%
389,521
-6,545
-2% -$294K
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.6B
$17.6M 1.01%
516,773
-13,179
-2% -$392K
NBIX icon
25
Neurocrine Biosciences
NBIX
$17B
$17.4M 1%
126,421
-5,200
-4% -$710K
1
2 3 4 5

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Rice Hall James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Rice Hall James & Associates held 275 positions worth $1.75B, up 1.4% from $1.73B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rice Hall James & Associates withdrew a net $74.5M in Q1 2024, closing 18 positions and reducing 162 holdings. Its most notable exit was PGT, Inc., an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in ADMA Biologics worth $7.96M.

  • Rice Hall James & Associates's largest Q1 2024 buy was ADMA Biologics: 1,206,499 shares worth $7.96M.
  • Rice Hall James & Associates added most to Alkermes in Q1 2024, an estimated $10.8M increase.
  • Rice Hall James & Associates's biggest Q1 2024 reduction was MASONITE INTERNATIONAL CORP, cutting an estimated $10.2M.
  • Rice Hall James & Associates fully exited PGT, Inc. in Q1 2024, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 28% of its $1.75B portfolio in Q1 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 18 in Q1 2024.
  • Rice Hall James & Associates's portfolio value rose 1.4% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q1 2024, filed 23 Apr 2024.